2-240783028-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001244008.2(KIF1A):​c.864+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,604,656 control chromosomes in the GnomAD database, including 39,854 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6631 hom., cov: 34)
Exomes 𝑓: 0.21 ( 33223 hom. )

Consequence

KIF1A
NM_001244008.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.763

Publications

9 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.014).
BP6
Variant 2-240783028-G-A is Benign according to our data. Variant chr2-240783028-G-A is described in ClinVar as [Benign]. Clinvar id is 283505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.864+16C>T intron_variant Intron 9 of 48 ENST00000498729.9 NP_001230937.1 Q12756-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.864+16C>T intron_variant Intron 9 of 48 5 NM_001244008.2 ENSP00000438388.1 Q12756-3

Frequencies

GnomAD3 genomes
AF:
0.272
AC:
41401
AN:
152006
Hom.:
6623
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.445
Gnomad AMI
AF:
0.149
Gnomad AMR
AF:
0.271
Gnomad ASJ
AF:
0.208
Gnomad EAS
AF:
0.339
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.198
Gnomad OTH
AF:
0.245
GnomAD2 exomes
AF:
0.219
AC:
54419
AN:
248348
AF XY:
0.207
show subpopulations
Gnomad AFR exome
AF:
0.443
Gnomad AMR exome
AF:
0.263
Gnomad ASJ exome
AF:
0.196
Gnomad EAS exome
AF:
0.327
Gnomad FIN exome
AF:
0.167
Gnomad NFE exome
AF:
0.200
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.205
AC:
297905
AN:
1452532
Hom.:
33223
Cov.:
31
AF XY:
0.200
AC XY:
144972
AN XY:
723286
show subpopulations
African (AFR)
AF:
0.454
AC:
15088
AN:
33268
American (AMR)
AF:
0.267
AC:
11934
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.197
AC:
5147
AN:
26082
East Asian (EAS)
AF:
0.374
AC:
14809
AN:
39634
South Asian (SAS)
AF:
0.107
AC:
9236
AN:
86102
European-Finnish (FIN)
AF:
0.171
AC:
9035
AN:
52972
Middle Eastern (MID)
AF:
0.206
AC:
1187
AN:
5754
European-Non Finnish (NFE)
AF:
0.198
AC:
218513
AN:
1103902
Other (OTH)
AF:
0.216
AC:
12956
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
10700
21399
32099
42798
53498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7766
15532
23298
31064
38830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.272
AC:
41421
AN:
152124
Hom.:
6631
Cov.:
34
AF XY:
0.268
AC XY:
19904
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.444
AC:
18442
AN:
41490
American (AMR)
AF:
0.271
AC:
4146
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
721
AN:
3470
East Asian (EAS)
AF:
0.339
AC:
1744
AN:
5152
South Asian (SAS)
AF:
0.107
AC:
514
AN:
4812
European-Finnish (FIN)
AF:
0.159
AC:
1688
AN:
10616
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.198
AC:
13451
AN:
67976
Other (OTH)
AF:
0.242
AC:
512
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1471
2943
4414
5886
7357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.209
Hom.:
7424
Bravo
AF:
0.290
Asia WGS
AF:
0.218
AC:
760
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Sep 22, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.15
DANN
Benign
0.67
PhyloP100
-0.76
PromoterAI
0.033
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288750; hg19: chr2-241722445; API